These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3975574)

  • 21. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.
    Graham S; Coote PJ
    J Antimicrob Chemother; 2007 Apr; 59(4):759-62. PubMed ID: 17324959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.
    Shah A; Mond J; Walsh S
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2704-7. PubMed ID: 15215130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Internally quenched peptides for the study of lysostaphin: An antimicrobial protease that kills Staphylococcus aureus.
    Warfield R; Bardelang P; Saunders H; Chan WC; Penfold C; James R; Thomas NR
    Org Biomol Chem; 2006 Oct; 4(19):3626-38. PubMed ID: 16990938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antiseptic effect of compound lysostaphin disinfectant and its preventive effect on infection of artificial dermis after graft on full-thickness skin defect wound in rats].
    Jin J; Zhou H; Cui ZC; Wang L; Luo PF; Ji SZ; Hu XY; Ma B; Wang GY; Zhu SH; Xia ZF
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):225-232. PubMed ID: 29690741
    [No Abstract]   [Full Text] [Related]  

  • 25. [Influence of Polycations on Antibacterial Activity of Lysostaphin].
    Kulikov SN; Khairullin RZ; Varlamov VP
    Prikl Biokhim Mikrobiol; 2015; 51(6):610-5. PubMed ID: 26859963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity.
    Severance PJ; Kauffman CA; Sheagren JN
    J Clin Microbiol; 1980 Jun; 11(6):724-7. PubMed ID: 7430338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes.
    Leijh PC; van den Barselaar MT; Dubbeldeman-Rempt I; van Furth R
    Eur J Immunol; 1980 Oct; 10(10):750-7. PubMed ID: 7000519
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of Staphylococcus aureus with a fluorescence in situ hybridization that does not require lysostaphin.
    Lawson TS; Connally RE; Iredell JR; Vemulpad S; Piper JA
    J Clin Lab Anal; 2011; 25(2):142-7. PubMed ID: 21438009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysostaphin: an antistaphylococcal agent.
    Kumar JK
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nisin and lysostaphin activity against preformed biofilm of Staphylococcus aureus involved in bovine mastitis.
    Ceotto-Vigoder H; Marques SL; Santos IN; Alves MD; Barrias ES; Potter A; Alviano DS; Bastos MC
    J Appl Microbiol; 2016 Jul; 121(1):101-14. PubMed ID: 26999597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-specific N-glycosylation of caprine lysostaphin restricts its bacteriolytic activity toward Staphylococcus aureus.
    Huang CY; Hsu JT; Chung PH; Cheng WT; Jiang YN; Ju YT
    Anim Biotechnol; 2013; 24(2):129-47. PubMed ID: 23534959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin.
    Francius G; Domenech O; Mingeot-Leclercq MP; Dufrêne YF
    J Bacteriol; 2008 Dec; 190(24):7904-9. PubMed ID: 18835985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcus simulans Recombinant Lysostaphin: Production, Purification, and Determination of Antistaphylococcal Activity.
    Boksha IS; Lavrova NV; Grishin AV; Demidenko AV; Lyashchuk AM; Galushkina ZM; Ovchinnikov RS; Umyarov AM; Avetisian LR; Chernukha MIu; Shaginian IA; Lunin VG; Karyagina AS
    Biochemistry (Mosc); 2016 May; 81(5):502-10. PubMed ID: 27297900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of intracellular growth of Staphylococcus aureus by exposure of infected human monocytes to clarithromycin and azithromycin.
    Fietta A; Merlini C; Gialdroni Grassi G
    J Chemother; 1997 Feb; 9(1):17-22. PubMed ID: 9106013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody-directed targeting of lysostaphin adsorbed onto polylactide nanoparticles increases its antimicrobial activity against S. aureus in vitro.
    Satishkumar R; Vertegel AA
    Nanotechnology; 2011 Dec; 22(50):505103. PubMed ID: 22107797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of various blood culture media on lysostaphin sensitivity of staphylococci.
    Severance PJ; Kauffman CA; Sheagren JN
    J Clin Microbiol; 1980 Nov; 12(5):709-10. PubMed ID: 7276143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectrophotometric detection of bacteriolytic activity of diluted lysostaphin solutions.
    Márová I; Kovár J
    Folia Microbiol (Praha); 1993; 38(2):153-8. PubMed ID: 8375782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of the composition of the reversion medium on the transformation of coccal forms and L-form of Staphylococcus aureus lysostaphin protoplasts].
    Kato Y; Hirachi Y; Toda Y; Kurono M; Takemasa N; Kotani S
    Osaka Daigaku Shigaku Zasshi; 1985 Dec; 30(2):296-303. PubMed ID: 3869230
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
    Climo MW; Ehlert K; Archer GL
    Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC; Foster-Frey J; Donovan DM
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.